Dermatomyositis and acute interstitial lung disease associated with MDA-5 antibodies: An atypical case

被引:13
|
作者
Girard, C. [1 ]
Vincent, T. [2 ]
Bessis, D. [1 ]
机构
[1] Univ Montpellier I, CHU, Hop St Eloi, Dept Dermatol, F-34295 Montpellier 5, France
[2] Univ Montpellier I, CHU, Hop St Eloi, Immunol Lab, F-34295 Montpellier 5, France
来源
关键词
Dermatomyositis; MDA-5; antibodies; Interstitial lung disease; Acquired ichthyosis; JAPANESE PATIENTS; GENE; 5; JUVENILE DERMATOMYOSITIS; INFLAMMATORY MYOPATHIES; AUTOANTIBODIES; CALCINOSIS; ANTI-MDA5; CADM-140; FEATURES; PROTEIN;
D O I
10.1016/j.annder.2013.04.083
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background. - A new antibody known as anti-MDA-5 has recently been identified in association with a specific phenotype of dermatomyositis (DM), in which muscular involvement is minimal or absent, but where there is a particularly high risk of onset of aggressive interstitial lung disease. Below, we report a case associated with the presence of anti-MDA-5 antibodies complicated by aggressive interstitial lung disease; the cutaneous phenotype of this patient is novel due to the constitution of diffuse ichthyosis and of profuse subcutaneous calcinosis. Patients and methods. - A 35-year-old man was hospitalised for a skin rash associated with arthralgia, dry cough, asthenia and weight-loss of 8 kg in 5 months. The dermatological examination revealed purple erythema of the upper eyelids and cheeks, diffuse acquired ichthyosis of the trunk and limbs, and striated erythema on the proximal and distal metacarpal and interphalangeal joints of the fingers. A diagnosis of DM was suspected in patients treated with prednisolone, 1.5 mg/kg/d. Immunological tests identified the presence of anti-MDA-5 antibodies. One month later, the cutaneous signs continued to progress and were marked by the development of painful ulcers on the back of the fingers, as well as dyspnoea accompanying the slightest effort. Chest images showed constituted pulmonary fibrosis lesions. At the same time, within several months, diffuse, pseudo-tumoural calcifications developed in the subcutaneous tissue of the trunk and limbs. The patient was treated successively with intravenous gammaglobulins, cyclophosphamide, mycophenolate mofetil, azathioprine and rituximab in combination with oral corticosteroids, but with no improvement in respiratory function or in the skin lesions. Because of the decline in the patient's respiratory status, a lung graft was envisaged but subsequently abandoned because of the patient's excessively precarious state of health. Discussion. - Anti-MDA-5 antibody appears to constitute a specific immunological marker for a special dermatological phenotype of adult DM, significantly associated with the presence of: 1) keratotic papules in the skin folds of the palms and fingers; 2) cutaneous ulcers along the periungueal edges, Gottron's papules on the back of the hands and on the extensor surface of the elbows and knees; 3) pain and ulceration in the oral mucosa, diffuse alopecia, and appearance of "mechanic's hands" and Gottron's sign on the elbows and knees. To our knowledge, the presence of extensive ichthyosis and profuse subcutaneous calcinosis has not been previously reported in this particular form of DM. The risk of aggressive interstitial lung disease is particularly high and worsens the prognosis, since 40% of patients with anti-MDA-5 die, usually within the first year. Conclusion. Herein, we describe a patient presenting amyopathic DM complicated by aggressive interstitial lung disease associated with the presence of anti-MDA-5 antibodies, but with a hitherto unreported cutaneous phenotype combining diffuse ichthyosis and profuse subcutaneous calcinosis. (C) 2013 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:628 / 634
页数:7
相关论文
共 50 条
  • [41] Serum ferritin correlates with activity of anti-MDA5 antibody-associated acute interstitial lung disease as a complication of dermatomyositis
    Gono, Takahisa
    Kawaguchi, Yasushi
    Ozeki, Eri
    Ota, Yuko
    Satoh, Takashi
    Kuwana, Masataka
    Hara, Masako
    Yamanaka, Hisashi
    MODERN RHEUMATOLOGY, 2011, 21 (02) : 223 - 227
  • [42] Rapid increase of serum anti-MDA-5 antibodies and exacerbation of clinically amyopathic dermatomyositis/interstitial lung disease
    Murase, C.
    Muro, Y.
    Akiyama, M.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2017, 31 (01) : E43 - E44
  • [43] Evaluating the value of superoxide dismutase in anti-MDA5-positive dermatomyositis associated with interstitial lung disease
    Huang, Wenhan
    Chen, Dandan
    Wang, Zhongjie
    Ren, Feifeng
    Luo, Lei
    Zhou, Jun
    Huang, Dongmei
    Tian, Mengxue
    Chen, Hong
    Tang, Lin
    RHEUMATOLOGY, 2023, 62 (03) : 1197 - 1203
  • [44] PJP as the Index Presentation for Anti-MDA5+Dermatomyositis with Associated Rapidly Progressive Interstitial Lung Disease
    Onofrey, L.
    Harper, A.
    Chung, S.
    Disharoon, S.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2022, 205
  • [45] Rituximab in the treatment of anti-MDA5 dermatomyositis-associated interstitial lung disease: a case-based literature review
    Nascimento, J.
    Tenazinha, C.
    Campanilho-Marques, R.
    Cordeiro, I
    Salgado, S.
    ARP RHEUMATOLOGY, 2022, 1 (02): : 168 - 173
  • [46] RAPIDLY PROGRESSIVE INTERSTITIAL LUNG DISEASE IN ASSOCIATION WITH MDA5 ANTIBODY DERMATOMYOSITIS
    Kazmierski, Dan
    Sharma, Nishant
    Wang, Yichen
    Noumi, Bassel
    Ochieng, Pius
    Ejaz, Komal
    CHEST, 2020, 158 (04) : 1140A - 1141A
  • [47] Anti-MDA5 positive dermatomyositis complicated with rapidly progressive interstitial lung disease - a case report
    De Backer, Eva
    Gremonprez, Felix
    Brusselle, Guy
    Depuydt, Pieter
    Van Dorpe, Jo
    Van Haverbeke, Carole
    Goeminne, Pieter C.
    Derom, Eric
    ACTA CLINICA BELGICA, 2018, 73 (06) : 413 - 417
  • [48] Assessment of anti-MDA5 antibody as a diagnostic biomarker in patients with dermatomyositis-associated interstitial lung disease or rapidly progressive interstitial lung disease
    Li, Liubing
    Wang, Qian
    Wen, Xiaoting
    Liu, Chenxi
    Wu, Chanyuan
    Yang, Funing
    Zeng, Xiaofeng
    Li, Yongzhe
    ONCOTARGET, 2017, 8 (44) : 76129 - 76140
  • [49] MDA5 expression is associated with TGF-β-induced fibrosis: potential mechanism of interstitial lung disease in anti-MDA5 dermatomyositis
    Shen, Ning
    Zhou, Xiaopeng
    Jin, Xuexiao
    Lu, Ci
    Hu, Xiuhua
    Zhang, Yichi
    Jiang, Yu
    Xu, Qin
    Xu, Xiayan
    Liu, Minghao
    Lu, Linrong
    Han, Yongmei
    RHEUMATOLOGY, 2022, 62 (01) : 373 - 383
  • [50] Prognostic values of anti-Ro52 antibodies in anti-MDA5-positive clinically amyopathic dermatomyositis associated with interstitial lung disease
    Xu, Antao
    Ye, Yan
    Fu, Qiong
    Lian, Xinyue
    Chen, Sheng
    Guo, Qiang
    Lu, Liang-jing
    Dai, Min
    Lv, Xia
    Bao, Chunde
    RHEUMATOLOGY, 2021, 60 (07) : 3343 - 3351